Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000711377-16-000098
Filing Date
2016-10-17
Accepted
2016-10-17 18:24:46
Documents
1
Period of Report
2016-10-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 3293
  Complete submission text file 0000711377-16-000098.txt   4590
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Issuer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 1007 MARKET STREET WILMINGTON DE 19898
Business Address
BOREL JAMES C (Reporting) CIK: 0001275972 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-17988 | Film No.: 161939591